ArticleWorld journal of psychiatry2025
Effect of lattice CO
Article in World journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Randomized Controlled Trial of Platelet-Rich Plasma Combined with Fractional COInternational urogynecology journal · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostpartum stress urinary incontinence (SUI) symptoms affect a patient's daily activities and quality of life and increase the negative emotions that they experience. At present, there is no research on the effect of fractional CO
aimTo investigate the effect of lattice CO
methodsUsing a retrospective study, data from 82 cases of mild to moderate postpartum SUI in Huzhou Maternal & Child Health Care Hospital from January to April 2024 were retrospectively collected. The cases were divided into groups according to the different treatment methods, namely Group S (41 cases, only receiving lattice CO
resultsThere was no significant difference in the baseline data and the ICI-Q-SF, I-QOL, EPDS, and PSAS scores between the two groups before treatment. However, at the end of treatment, the ICI-Q-SF, I-QOL, EPDS, and PSAS scores between Groups L and S were significantly different. The overall effective rate of treatment in Group L was significantly higher than that in Group S. During the 3-month follow-up after treatment, it was found that the ICI-Q-SF, EPDS, and PSAS scores of Group L were still lower than those of Group S. In comparison, the I-QOL score and total effective rate of treatment were still higher in Group L than those in Group S, and this difference was significant. There was no significant difference in the adverse reactions between Group L and Group S.
conclusionThe combination of dot lattice CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.